Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
Food and Drug Administration
Description
This grant opportunity aims to fund clinical trials focusing on the effectiveness and safety of products for new uses or labeling changes to meet unmet needs in rare diseases. The goal is to increase the number of approved treatments for rare diseases by supporting collaborative, efficient, and innovative trials, ultimately having a broad and positive impact on drug development for these conditions.
The purpose of this opportunity is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions. Additionally, through the funding of collaborative, efficient, and/or innovat…
Source
Grant ID
FOR-FD-25-020
Funding Source
Food and Drug Administration
Eligibility
The following categories of applicants are invited to apply:
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Links
Similar opportunities
- Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required
- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01)
- Notice of Funding Opportunity (NOFO) for Clinical Trials of Orphan Products
- Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
- Efficient and Innovative Natural History Studies for Rare Diseases